Tomosynthesis Plus Synthesized Mammography Reduces Unnecessary Recalls, Boosts Cancer Detection:...

Germany: Digital breast tomosynthesis (DBT) combined with synthesized mammography (SM) reduces false-positive recall rates while detecting more breast cancers compared with standard digital mammography (DM), according to a subanalysis of the TOSYMA trial published September 16 in Radiology . The approach appears particularly effective for women undergoing their first mammography screening, although it slightly increases false-positive biopsy rates. Led by Stefanie Weigel, MD, from the University of Münster and University Hospital Münster in Germany, the study analyzed data from nearly 100,000 participants in the TOmo-synthesis plus SYnthesized MAmmography (TOSYMA) trial, conducted between 2018 and 2020. The subanalysis focused on comparing false-positive recall and biopsy rates